Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data

• Published in: The Journal of infectious diseases Vol. 225; no. 8; pp. 1415 - 1423
• Main Authors: Fraser, Maya, Miller, John M, Silumbe, Kafula, Hainsworth, Michael, Mudenda, Mutinta, Hamainza, Busiku, Moonga, Hawela, Chizema Kawesha, Elizabeth, Mercer, Laina D, Bennett, Adam, Schneider, Kammerle, Slater, Hannah C, Eisele, Thomas P, Guinovart, Caterina
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 19.04.2022
• Subjects: Antimalarials - therapeutic use; Catchment areas; Dihydroartemisinin; Disease control; Drug therapy; Humans; Incidence; Major and Brief Reports; Malaria; Malaria - drug therapy; Malaria - epidemiology; Malaria - prevention & control; Mass Drug Administration; Public health; Zambia - epidemiology; Zambia; impact evaluation; routine data; mass drug administration; malaria
• ISSN: 0022-1899; 1537-6613
• DOI: 10.1093/infdis/jiaa434

Abstract Background In 2016, the Zambian National Malaria Elimination Centre started programmatic mass drug administration (pMDA) campaigns with dihydroartemisinin-piperaquine as a malaria elimination tool in Southern Province. Two rounds were administered, 2 months apart (coverage 70% and 57%, respectively). We evaluated the impact of 1 year of pMDA on malaria incidence using routine data. Methods We conducted an interrupted time series with comparison group analysis on monthly incidence data collected at the health facility catchment area (HFCA) level, with a negative binomial model using generalized estimating equations. Programmatic mass drug administration was conducted in HFCAs with greater than 50 cases/1000 people per year. Ten HFCAs with incidence rates marginally above this threshold (pMDA group) were compared with 20 HFCAs marginally below (comparison group). Results The pMDA HFCAs saw a 46% greater decrease in incidence at the time of intervention than the comparison areas (incidence rate ratio = 0.536; confidence interval = 0.337–0.852); however, incidence increased toward the end of the season. No HFCAs saw a transmission interruption. Conclusions Programmatic mass drug administration, implemented during 1 year with imperfect coverage in low transmission areas with suboptimal vector control coverage, significantly reduced incidence. However, elimination will require additional tools. Routine data are important resources for programmatic impact evaluations and should be considered for future analyses. This study evaluated 1 year of programmatic mass drug administration (pMDA) on malaria incidence in southern Zambia and found that areas where pMDA was conducted saw a 46% greater decrease in incidence at the time of intervention than comparison areas.